Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 10
Submit an article Journal homepage
95
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Aberrant expression of CD5 in adult acute myeloid leukemia belonged to AML-MR, may represent a uniquely aggressive subcategory

Yan ZhangDepartment of Hematology, The First Affiliated Hospital of China Medical University, Shenyang, ChinaORCID Iconhttps://orcid.org/0000-0001-6684-8985View further author information
ORCID Icon,
Yuanyi DingDepartment of Hematology, The First Affiliated Hospital of China Medical University, Shenyang, ChinaView further author information
,
Rui ZhangDepartment of Hematology, The First Affiliated Hospital of China Medical University, Shenyang, ChinaView further author information
,
Lijun ZhangDepartment of Hematology, The First Affiliated Hospital of China Medical University, Shenyang, ChinaView further author information
,
Xiaojing YanDepartment of Hematology, The First Affiliated Hospital of China Medical University, Shenyang, ChinaView further author information
&
Pingping WangDepartment of Hematology, The First Affiliated Hospital of China Medical University, Shenyang, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1900-623XView further author information
ORCID Icon
Pages 1711-1714 | Received 07 Nov 2023, Accepted 18 Mar 2023, Published online: 03 Jul 2023
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Disclosure statement

No potential conflict of interest was reported by the authors.

Patient consent

All subjects provided informed consent for testing.

Data availability statement

Data sharing is not applicable to this article as no new data were created or analyzed in this study.

Additional information

Funding

This work was supported by the ‘Science and technology plan projects of Liaoning Province’ grant (grant number: 2021-MS-190).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.